Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 323

1.

Characteristics of HPV infection over time in European women who are HIV-1 positive.

Heard I, Cubie HA, Mesher D, Sasieni P; MACH-1 Study Group.

BJOG. 2013 Jan;120(1):41-9. doi: 10.1111/1471-0528.12015. Epub 2012 Nov 2.

2.

A longitudinal study of HPV detection and cervical pathology in HIV infected women.

Cubie HA, Seagar AL, Beattie GJ, Monaghan S, Williams AR.

Sex Transm Infect. 2000 Aug;76(4):257-61.

3.

Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.

Hawes SE, Critchlow CW, Sow PS, Touré P, N'Doye I, Diop A, Kuypers JM, Kasse AA, Kiviat NB.

J Natl Cancer Inst. 2006 Jan 18;98(2):100-9.

4.

Human papillomavirus infection and cervical disease in human immunodeficiency virus-1-infected women.

Denny L, Boa R, Williamson AL, Allan B, Hardie D, Stan R, Myer L.

Obstet Gynecol. 2008 Jun;111(6):1380-7. doi: 10.1097/AOG.0b013e3181743327.

PMID:
18515522
5.

Human papillomavirus types among women infected with HIV: a meta-analysis.

Clifford GM, Gonçalves MA, Franceschi S; HPV and HIV Study Group.

AIDS. 2006 Nov 28;20(18):2337-44.

PMID:
17117020
6.

Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.

Verguts J, Bronselaer B, Donders G, Arbyn M, Van Eldere J, Drijkoningen M, Poppe W.

BJOG. 2006 Nov;113(11):1303-7. Epub 2006 Sep 15.

7.

Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.

Schlecht NF, Platt RW, Duarte-Franco E, Costa MC, Sobrinho JP, Prado JC, Ferenczy A, Rohan TE, Villa LL, Franco EL.

J Natl Cancer Inst. 2003 Sep 3;95(17):1336-43.

8.

Human papillomavirus infection in HIV-1 infected women in Catalonia (Spain): implications for prevention of cervical cancer.

Stuardo V, Agustí C, Godinez JM, Montoliu A, Torné A, Tarrats A, Alcalde C, Martín D, Fernández-Montoli E, Vanrell C, Solé J, Canet Y, Marqueta JM, Mohamed J, Cuenca I, Lonca M, Sirera G, Ferrer E, Domingo P, Lloveras B, Miro JM, De Sanjosé S, Casabona J.

PLoS One. 2012;7(10):e47755. doi: 10.1371/journal.pone.0047755. Epub 2012 Oct 30.

9.

Human papillomavirus genotype distribution in cervical samples collected in routine clinical practice at the Nantes University Hospital, France.

Vaucel E, Coste-Burel M, Laboisse C, Dahlab A, Lopes P.

Arch Gynecol Obstet. 2011 Oct;284(4):989-98. doi: 10.1007/s00404-010-1747-z. Epub 2010 Nov 25.

10.

Evolution of cervical abnormalities among women with HIV-1: evidence from surveillance cytology in the women's interagency HIV study.

Massad LS, Ahdieh L, Benning L, Minkoff H, Greenblatt RM, Watts H, Miotti P, Anastos K, Moxley M, Muderspach LI, Melnick S.

J Acquir Immune Defic Syndr. 2001 Aug 15;27(5):432-42.

PMID:
11511819
11.

Prevalence of human papillomavirus and the correlation of HPV infection with cervical disease in Weihai, China.

Yang L, He Z, Huang XY, Liu HN, Tao JY.

Eur J Gynaecol Oncol. 2015;36(1):73-7.

PMID:
25872339
12.

Type-specific oncogenic human papillomavirus infection in high grade cervical disease in New Zealand.

Simonella LM, Lewis H, Smith M, Neal H, Bromhead C, Canfell K.

BMC Infect Dis. 2013 Mar 3;13:114. doi: 10.1186/1471-2334-13-114.

13.

Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results.

Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, Minkoff H, Hall CB, Bacon MC, Levine AM, Watts DH, Silverberg MJ, Xue X, Melnick SL, Strickler HD.

JAMA. 2005 Mar 23;293(12):1471-6.

PMID:
15784870
14.

Multiple human papillomavirus infections with high viral loads are associated with cervical lesions but do not differentiate grades of cervical abnormalities.

Schmitt M, Depuydt C, Benoy I, Bogers J, Antoine J, Arbyn M, Pawlita M; VALGENT Study Group.

J Clin Microbiol. 2013 May;51(5):1458-64. doi: 10.1128/JCM.00087-13. Epub 2013 Feb 27.

15.

Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain.

Otero-Motta AP, Ordóñez JL, González-Celador R, Rivas B, Macías Mdel C, Bullón A, Abad Mdel M.

APMIS. 2011 Mar;119(3):204-15. doi: 10.1111/j.1600-0463.2010.02711.x. Epub 2011 Jan 25.

PMID:
21284738
16.

A survey on the prevalence of high-risk subtypes of human papilloma virus among women with cervical neoplasia in Isfahan University of Medical Science.

Allameh T, Moghim S, Asadi-Zeidabadi M.

Arch Gynecol Obstet. 2011 Dec;284(6):1509-13. doi: 10.1007/s00404-011-1863-4. Epub 2011 Mar 9.

PMID:
21387088
18.

Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection with human immunodeficiency virus.

Moscicki AB, Ellenberg JH, Vermund SH, Holland CA, Darragh T, Crowley-Nowick PA, Levin L, Wilson CM.

Arch Pediatr Adolesc Med. 2000 Feb;154(2):127-34.

PMID:
10665598
19.

HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India.

Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV.

PLoS One. 2012;7(6):e38731. doi: 10.1371/journal.pone.0038731. Epub 2012 Jun 19.

Items per page

Supplemental Content

Write to the Help Desk